Predicting druggable binding sites at the protein???protein interface, Drug Discovery Today, vol.14, issue.3-4, pp.155-161, 2009. ,
DOI : 10.1016/j.drudis.2008.10.009
iPPI-DB: an online database of modulators of protein???protein interactions, Nucleic Acids Research, vol.44, issue.D1, pp.542-547, 2016. ,
DOI : 10.1093/nar/gkv982
2P2Idb v2: update of a structural database dedicated to orthosteric modulation of protein-protein interactions. Database: the journal of biological databases and curation, pp.10-1093, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01307114
)-based irreversible protein???protein interaction inhibitor of BRD4 as a potent anticancer agent, Chemical Science, vol.141, issue.10, pp.5400-5408, 2015. ,
DOI : 10.1016/j.cell.2010.03.030
Identification of an Iridium(III)-Based Inhibitor of Tumor Necrosis Factor-??, Journal of Medicinal Chemistry, vol.59, issue.8, pp.4026-4031, 2016. ,
DOI : 10.1021/acs.jmedchem.6b00112
Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds, Oncotarget, vol.7, issue.12, pp.13965-139757369, 2016. ,
DOI : 10.18632/oncotarget.7369
Dendrimer Space Exploration: An Assessment of Dendrimers/Dendritic Scaffolding as Inhibitors of Protein???Protein Interactions, a Potential New Area of Pharmaceutical Development, Chemical Reviews, vol.114, issue.2, pp.1327-134210, 2014. ,
DOI : 10.1021/cr400362r
Protein???protein interaction inhibitors get into the groove, Nature Reviews Drug Discovery, vol.468, issue.3, pp.173-175, 2012. ,
DOI : 10.1038/nature09504
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality, Chemistry & Biology, vol.21, issue.9, pp.1102-1114, 2014. ,
DOI : 10.1016/j.chembiol.2014.09.001
Reaching for high-hanging fruit in drug discovery at protein???protein interfaces, Nature, vol.12, issue.7172, pp.1001-1009, 2007. ,
DOI : 10.1128/MCB.17.12.7040
Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins, Journal of Medicinal Chemistry, vol.51, issue.21, pp.6902-6915, 2008. ,
DOI : 10.1021/jm800669s
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets, Nature Medicine, vol.559, issue.2, pp.202-2083048, 2013. ,
DOI : 10.1038/leu.2009.151
Unraveling structural mechanisms of allosteric drug action, Trends in Pharmacological Sciences, vol.35, issue.5, pp.256-264, 2014. ,
DOI : 10.1016/j.tips.2014.03.006
Signalling pathways of the TNF superfamily: a double-edged sword, Nature Reviews Immunology, vol.3, issue.9, pp.745-756, 2003. ,
DOI : 10.1038/nri1184
Considerations with the use of biological therapy in the treatment of rheumatoid arthritis, Expert Opinion on Drug Safety, vol.1, issue.4, pp.391-403, 2004. ,
DOI : 10.1136/gut.50.2.206
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review, Arthritis Research & Therapy, vol.11, issue.Suppl 1, p.1, 2009. ,
DOI : 10.1186/ar2666
Small-Molecule Inhibition of TNF-??, Science, vol.310, issue.5750, pp.1022-1025, 2005. ,
DOI : 10.1126/science.1116304
Rationally Designed Less Toxic SPD-304 Analogs and Preliminary Evaluation of Their TNF Inhibitory Effects, Archiv der Pharmazie, vol.227, issue.11, pp.798-80510, 2014. ,
DOI : 10.1038/227680a0
Discovery of the inhibitors of tumor necrosis factor alpha with structure-based virtual screening, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.21, pp.6195-6198, 2010. ,
DOI : 10.1016/j.bmcl.2010.08.116
Structure-Based Repurposing of FDA-Approved Drugs as TNF-?? Inhibitors, ChemMedChem, vol.70, issue.5, pp.765-768, 2011. ,
DOI : 10.1124/mol.106.028480
Inhibition of tumor necrosis factor-?? (TNF-??)/ TNF-?? receptor binding by structural analogues of suramin????Abbreviations: TNF-??, tumor necrosis factor-??; and MC/EM, MonteCarlo/energy minimization., Biochemical Pharmacology, vol.58, issue.5, pp.851-859, 1999. ,
DOI : 10.1016/S0006-2952(99)00150-1
Suramin induces deoligomerization of human tumor necrosis factor alpha, J Biol Chem, vol.268, pp.12526-12529, 1993. ,
DOI : 10.1021/bi00019a012
Structure-Based Discovery of Natural-Product-like TNF-?? Inhibitors, Angewandte Chemie International Edition, vol.2, issue.16, pp.2860-2864, 2010. ,
DOI : 10.1002/asia.200700125
A Metal-Based Inhibitor of Tumor Necrosis Factor-??, Angewandte Chemie International Edition, vol.29, issue.36, pp.9010-901410, 2012. ,
DOI : 10.1002/(SICI)1097-0134(1997)1+<215::AID-PROT29>3.0.CO;2-Q
Discovery of TNF Inhibitors from a DNA-Encoded Chemical Library based on Diels-Alder Cycloaddition, Chemistry & Biology, vol.16, issue.10, pp.1075-1086011, 2009. ,
DOI : 10.1016/j.chembiol.2009.09.011
Japonicone A antagonizes the activity of TNF-?? by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1, Biochemical Pharmacology, vol.84, issue.11, pp.1482-1491025, 2012. ,
DOI : 10.1016/j.bcp.2012.08.025
A Novel Small-molecule Tumor Necrosis Factor ?? Inhibitor Attenuates Inflammation in a Hepatitis Mouse Model, Journal of Biological Chemistry, vol.10, issue.18, pp.12457-1246610, 2014. ,
DOI : 10.1038/sj.bjp.0702747
Galactosamine-induced sensitization to the lethal effects of endotoxin., Proceedings of the National Academy of Sciences, vol.76, issue.11, pp.5939-5943, 1979. ,
DOI : 10.1073/pnas.76.11.5939
Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice, Infect Immun, vol.59, pp.2110-2115, 1991. ,
3424 | DOI:10.1038/s41598-017-03427-z 30 Measurement of two-dimensional binding constants between cell-bound major histocompatibility complex and immobilized antibodies with an acoustic biosensor, Biophys J, vol.7108, issue.95, pp.4963-4971132118, 2008. ,
SH-SAW sensors: investigations on macromolecules effects on binding kinetic constants, The European Physical Journal Applied Physics, vol.134, issue.1, pp.13705-13709, 2011. ,
DOI : 10.1016/j.snb.2008.04.016
URL : https://hal.archives-ouvertes.fr/hal-00736288
Immunosensing with surface acoustic wave sensors: toward highly sensitive and selective improved piezoelectric biosensors. New sensors and processing chain, pp.978-979, 2014. ,
DOI : 10.1002/9781119050612.ch3
Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-??/SPD304 Study, ACS Medicinal Chemistry Letters, vol.4, issue.1, pp.137-14110, 2013. ,
DOI : 10.1021/ml300380h
Surflex:?? Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine, Journal of Medicinal Chemistry, vol.46, issue.4, pp.499-511, 2003. ,
DOI : 10.1021/jm020406h
Lymphotoxin alpha revisited: general features and implications in rheumatoid arthritis, Arthritis Res Ther, vol.13, issue.232, pp.10-1186, 2011. ,
DOI : 10.1186/ar3376
URL : https://arthritis-research.biomedcentral.com/track/pdf/10.1186/ar3376?site=arthritis-research.biomedcentral.com
Etanercept decreases synovial expression of tumour necrosis factor-?? and lymphotoxin-?? in rheumatoid arthritis, Scandinavian Journal of Rheumatology, vol.47, issue.2, pp.85-9010, 2014. ,
DOI : 10.1093/rheumatology/ken261
True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin ???, Annals of the Rheumatic Diseases, vol.63, issue.10, pp.1344-1346014878, 2003. ,
DOI : 10.1136/ard.2003.014878
UCSF Chimera?A visualization system for exploratory research and analysis, Journal of Computational Chemistry, vol.373, issue.13, pp.1605-1612, 2004. ,
DOI : 10.1002/jcc.20084
URL : http://www.cgl.ucsf.edu/home/tef/pubs/chimera.pdf
FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects, BMC Bioinformatics, vol.9, issue.1, p.396, 2008. ,
DOI : 10.1186/1471-2105-9-396
URL : https://bmcbioinformatics.biomedcentral.com/track/pdf/10.1186/1471-2105-9-396?site=bmcbioinformatics.biomedcentral.com